-
Thematic Analysis
NewMedia M&A Deals Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Media Sector. The media M&A market in Q1 2024 witnessed deals worth $33 billion, an increase of 16% compared to Q1 2023. In terms of deal volume, there was a 8% fall from 432 deals in Q1 2023 to 397 M&A deals in Q1 2024. This year recorded 11 mega deals (defined as any deal valued at or more than $1 billion), 267% increase...
-
Thematic Analysis
NewTech, Media and Telecom (TMT) M&A Deals Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the TMT Sector. The TMT M&A market in Q1 2024 witnessed deals worth $186 billion, a growth of 44% compared to Q1 2023. In terms of deal volume, there was an 11% fall from 2,419 deals in Q1 2023 to 2,163 M&A deals in Q1 2024. This year recorded 42 mega deals (defined as any deal valued at or more than $1 billion), 83% growth...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lenvatinib Mesylate in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lenvatinib Mesylate in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data....
-
Thematic Analysis
NewEnterprise Security Software Sector Scorecard, Q1 2024 Update – Thematic Intelligence
Artificial intelligence (AI) is a double-edged sword in cybersecurity. It can help organizations improve their threat detection, hunting, and incident response capabilities, but adversaries can and will use AI in cyberattacks. There is every likelihood that AI will spur new merger and acquisition (M&A) deals in cybersecurity, especially of companies judged to be AI specialists. In the thematic screen of GlobalData’s enterprise security software sector scorecard, AI has a weighting of 20%, higher than any other theme.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Teserpaturev in Malignant Pleural Mesothelioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Teserpaturev in Malignant Pleural Mesothelioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Teserpaturev in Malignant Pleural Mesothelioma Drug Details: Teserpaturev (Delytact) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ficerafusp Alfa in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ficerafusp Alfa in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ficerafusp Alfa in Colorectal Cancer Drug Details: Ficerafusp alfa (BCA-101)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ficerafusp Alfa in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ficerafusp Alfa in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ficerafusp Alfa in Pancreatic Cancer Drug Details: Ficerafusp alfa (BCA-101)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ficerafusp Alfa in Recurrent Head And Neck Squamous Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ficerafusp Alfa in Recurrent Head And Neck Squamous Cell Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ficerafusp Alfa in Recurrent Head...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ficerafusp Alfa in Cutaneous Squamous Cell Carcinoma (cSCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ficerafusp Alfa in Cutaneous Squamous Cell Carcinoma (cSCC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ficerafusp Alfa in Cutaneous Squamous Cell Carcinoma...
-
Sector Analysis
NewIran Cards and Payments – Opportunities and Risks to 2028
Iran Cards and Payments Market Report Overview The annual value of card transactions in the Iran cards and payments market was $3.9 trillion in 2023. The value will grow at a CAGR of more than 18% during 2024-2028 owing to the improvements to the country’s payments infrastructure and an increase in the number of retailers accepting payment cards. Iran Card Transactions Outlook, 2023-2028 ($ Trillion) Buy the Full Report for More Information on the Iran Cards and Payments Market Forecast...